Cargando…
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost
COVID-19 is an ongoing viral pandemic disease that is caused by SARS-CoV2, inducing severe pneumonia in humans. However, several classes of repurposed drugs have been recommended, no specific vaccines or effective therapeutic interventions for COVID-19 are developed till now. Viral dependence on ACE...
Autores principales: | Mohammed El Tabaa, Manar, Mohammed El Tabaa, Maram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250789/ https://www.ncbi.nlm.nih.gov/pubmed/32470547 http://dx.doi.org/10.1016/j.bcp.2020.114057 |
Ejemplares similares
-
Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]
por: Mohammed El Tabaa, Manar, et al.
Publicado: (2020) -
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19
por: El Tabaa, Manar Mohammed, et al.
Publicado: (2020) -
Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn/GDNF and MAPK signaling pathway
por: Tabaa, Manar Mohammed El, et al.
Publicado: (2022) -
Does ( −)-epigallocatechin-3-gallate protect the neurotoxicity induced by bisphenol A in vivo?
por: El Tabaa, Manar Mohammed, et al.
Publicado: (2022) -
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension
por: Alves-Lopes, Rhéure, et al.
Publicado: (2021)